Use of combinations of antipsychotics: McLean Hospital inpatients, 2002

Human Psychopharmacology

Volumn 20, Issue 7, 2005, Pages 485-492

  Centorrino, Franca ^a,b   Fogarty, Kate V ^b   Sani, Gabriele ^b   Salvatore, Paola ^a,b,c   Cincotta, Stephanie L ^b   Hennen, John ^b   Guzzetta, Francesca ^b   Talamo, Alessandra ^b   Saadeh, Mark G ^b   Baldessarini, Ross J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Antipsychotics; Bipolar disorder; Combination; Polypharmacy; Polytherapy; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SEDATIVE AGENT; ZIPRASIDONE;

ADULT; AFFECTIVE PSYCHOSIS; AGE DISTRIBUTION; AGITATION; ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG USE; EXCITEMENT; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MONOTHERAPY; POLYPHARMACY; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SEX DIFFERENCE; SYMPTOMATOLOGY;

ADULT; ANTIPSYCHOTIC AGENTS; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; INPATIENTS; LENGTH OF STAY; MALE; PATIENT DISCHARGE; PHARMACY SERVICE, HOSPITAL; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; TREATMENT OUTCOME;

EID: 27144462032     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.719     Document Type: Article

References (27)

1. Anonymous. 1999. Treatment of schizophrenia 1999. The expert consensus guideline series. J Clin Psychiatry 60(Suppl. 11): 3-80.
2. Bacher NM, Kaup BA. 1996. Combining risperidone with standard neuroleptics for refractory schizophrenia patients. Am J Psychiatry 153: 137.
3. Baldessarini RJ, Tarazi FI. 2005. Drugs and the treatment of psychiatric disorders: antipsychotic and antimanic agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics (11th edn), Hardman JG, Limbird LE, Gilman AG (eds). McGraw-Hill: New York.
4. Centorrino F, Eakin M, Bahk W-M, et al. 2002. Inpatient antipsychotic drug use in 1998: Comparisons to 1993 and 1989. Am J Psychiatry 159: 1932-1935.
5. Centorrino F, Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ. 2004. Multiple vs single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks vs benefits. Am J Psychiatry 161: 700-706.
6. Emsley R, Rabinowitz J, Torreman M. 2003. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophrenia Res 61: 47-57.
7. Freudenreich O, Goff DC. 2002. Antipsychotic combination therapy in schizophrenia: review of efficacy and risks of current combinations. Acta Psychiatr Scand 106: 323-330.
8. Friedman J, Ault K, Powchik P. 1997. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine. Biol Psychiatry 42: 522-523.
9. Ganguly R, Kotzan JA, Miller LS, Kennedy K, Martin BC. 2004. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000. J Clin Psychiatry 65: 1377-1388.
10. Goss JB. 1995. Concomitant use of thioridazine with risperidone. Am J Health Syst Pharm 52: 1012.
11. Gupta S, Sonnenberg SJ, Frank B. 1998. Olanzapine augmentation of clozapine. Ann Clin Psychiatry 10: 113-115.
12. Henderson DC, Goff DC. 1996. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics. J Clin Psychiatry 57: 395-397.
13. 2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry 50: 873-883.
14. Lerner V, Libov I, Kotler M, Strous RD. 2004. Combination of 'atypical' antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder. Prog Neuropsychopharmacol Biol Psychiatry 28: 89-98.
15. McCarthy RH, Terkelsen KG. 1995. Risperidone augmentation of clozapine. Pharmacopsychiatry 28: 61-63.
16. McCue RE, Waheed R, Urcuyo L. 2003. Polypharmacy in patients with schizophrenia. J Clin Psychiatry 64: 984-989.
17. Meltzer HY, Kostokaglu AE. 2002. Combining antipsychotics: is there evidence of efficacy? Psychiatr Times Sept: 25-34.
18. Millen AL. 2004. Combination treatments for schizophrenia. CNS Spectrums 9(Suppl. 9): 19-23.
19. Oepen G. 2002. Polypharmacy in schizophrenia. In Polypharmacy in Psychiatry, Ghaemi SN (ed.). Marcel Dekker: New York.
20. Schumacher JE, Makela EH, Griffin HR. 2003. Multiple antipsychotic medication prescribing patterns. Ann Pharmacother 37: 951-955.
21. Shiloh R, Zemishlany Z, Aizenberg D, et al. 1997. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled study. Br J Psychiatry 171: 569-573.
22. Stahl SM. 1999a. Antipsychotic polypharmacy: therapeutic option or dirty little secret? J Clin Psychiatry 60: 425-426.
23. Stahl SM. 1999b. Antipsychotic polypharmacy: tips on use and misuse. J Clin Psychiatry 60: 506-507.
24. Takhar J. 1999. Pimozide augmentation in a patient with drug-resistant psychosis previously treated with olanzapine. J Psychiatry Neurosci 24: 248-249.
25. Tapp A, Wood AE, Secrest L, Erdmann J, Cubberley L, Kilzieh N. 2003. Combination antipsychotic therapy in clinical practice. Psychiatr Serv 54: 55-59.
26. Waring EW, Devin PG, Dewan V. 1999. Treatment of schizophrenia with antipsychotics in combination. Can J Psychiatry 55: 189-190.
27. Woods S. 2003. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64: 663-667.